Literature DB >> 6310193

Clinico-pathological studies on ovarian metastasis from gastric cancer.

M Hirono, K Taniyama, K Matsuki, K Nakagami, M Niimoto, T Hattori.   

Abstract

Thirty autopsied female patients with gastric cancer were investigated clinico-pathologically, regarding ovarian metastases. According to the histological pattern of the ovarian metastases, there were five types; no-metastasis in five, capsular type (cancer involvement confined to the capsule) in three, hilar type (carcinoma is evident in the hilus but not in the cortex or medulla) in four, multifocal type (multifocal growth of cancer in the cortex and/or medulla) in eight and diffuse type (diffuse proliferation of cancer) in ten. Although marked peritoneal dissemination was noted in 27, the capsule of the ovaries was usually intact. These results suggest that in the development of ovarian metastasis, cancer cells first reach the hilus, then spread into the medulla or cortex multifocally, and later grow diffusely. While cancer cells reach and cover the capsule of the ovary in many instances, they seldom break and invade it. All seven patients, except one unknown patient, with no-metastasis and with the capsular type were postmenopausal, while one hilar, two multifocal and five diffuse type women were premenopausal. This indicates an "affinity" of ovarian tissue for cancer cells, in younger patients.

Entities:  

Mesh:

Year:  1983        PMID: 6310193     DOI: 10.1007/bf02469686

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  1 in total

1.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03
  1 in total
  1 in total

1.  Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer.

Authors:  Xiaoyan Zuo; Bo Li; Chengxu Zhu; Zheng-Wen Yan; Miao Li; Xinyi Wang; Yu-Juan Zhang
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.